According to the latest analysis conducted by Market Research Future (MRFR), the global anal cancer market is predicted to amass a substantial market growth, expanding at a CAGR of 6.46% during the anticipated period from 2017 to 2027.
The most significant factors stimulating the global anal cancer market 2020 is the increasing geriatric population, sexually transmitted diseases, smoking, and multiple sexual partners. As per the World Health Organization, millions of women across the globe are combating human papillomavirus infection (HPV), and unhealthy sex multiplies the chances of being infected with anal cancer. The prevalence of cancer has escalated the demand for a cure, which has resulted in increased research and development in the field of oncology.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1530
In order to prevent the disease, an early diagnosis is a mandate which is available only in developing countries. The developing and underdeveloped countries generally result in being a victim of the disease owing to the lack of expertise and awareness, which is the prime factor impeding the market. However, the escalating urgency to determine the solution to lethal diseases is projected to counter the market inhibiting factors.
Market Segmentation
The segment assessment of the global anal cancer market is done by treatment type, cancer type, and end-user.
The treatment type based segments of the global anal cancer market are chemotherapy, surgery, radiation therapy, and immunotherapy.
The cancer type based segments of the global anal cancer market are carcinoma in situ, squamous cell carcinoma, melanoma, adenocarcinoma, basal cell carcinoma, and others.
The end-user based segments of the global anal cancer market are hospitals & clinics, research & academic institutes, and others.
Regional Analysis
Based on geography, the global anal market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
As per the analysis, the Americas are estimated to dominate the global market owing to the surging prevalence of anal cancer. Further, the increasing health expenditure, well-developed healthcare sector, and the presence of established players are likely to be some of the most significant factors driving the regional market during the forecast period.
Europe is anticipated to procure the second-largest market share of the anal cancer due to the increasing prevalence of cancer and the participation established players such as Hoffmann-La Roche Ltd, and others. As per Cancer Research UK, there were new 1,438 cases of anal cancer detected from 2014 to 2016 in the UK.
The APAC region is projected to be the fastest-growing market due to the growing awareness of cancer in various countries. Further, the increasing prevalence of STDs is another major factor boosting the regional market. Besides, the presence of developing countries has multiplied the expansion of the market, owing to the increased focus on developing the healthcare infrastructure. Also, the constant rise in the number of patients is likely to stimulate market growth further. In the APAC, India and China are anticipated to play a vital role in developing the regional market by increased R&D and other market favorable initiatives.
On the contrary, the MEA region is estimated to procure the least market share owing to the stringent government policies, lack of awareness, presence of a sluggish economy, and underdeveloped healthcare infrastructure.
Key Players
Bristol-Myers Squibb Company (US), Amgen Inc. (US), Celgene Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Merck & Co., Inc. (US), Pfizer Inc. (US), Novartis AG (Switzerland), GlaxoSmithKline plc (UK), Johnson & Johnson Services, Inc. (US) Sanofi (France), and Hospira, Inc. (US) are some of the key players of the global anal cancer market.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/anal-cancer-market-1530
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
No comments:
Post a Comment